FGFR2/3-Altered Intrahepatic Cholangiocarcinoma: A Distinct Clinicopathologic and Molecular Subtype Associated with Improved Disease-Specific Survival

Wen-Yu Hsiao, Kartik Angara, Haider A. Mejbel

Open source

DOI
10.1016/j.modpat.2026.101094
Published
2026-12
Container
Modern Pathology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.modpat.2026.101094,
  title = {FGFR2/3-Altered Intrahepatic Cholangiocarcinoma: A Distinct Clinicopathologic and Molecular Subtype Associated with Improved Disease-Specific Survival},
  author = {Wen-Yu Hsiao and Kartik Angara and Haider A. Mejbel},
  year = {2026},
  journal = {Modern Pathology},
  doi = {10.1016/j.modpat.2026.101094},
  url = {https://doi.org/10.1016/j.modpat.2026.101094}
}

RIS

TY  - JOUR
TI  - FGFR2/3-Altered Intrahepatic Cholangiocarcinoma: A Distinct Clinicopathologic and Molecular Subtype Associated with Improved Disease-Specific Survival
AU  - Wen-Yu Hsiao
AU  - Kartik Angara
AU  - Haider A. Mejbel
PY  - 2026
JO  - Modern Pathology
DO  - 10.1016/j.modpat.2026.101094
UR  - https://doi.org/10.1016/j.modpat.2026.101094
ER  - 

APA

Hsiao, W., Angara, K., & Mejbel, H. A. (2026). FGFR2/3-Altered Intrahepatic Cholangiocarcinoma: A Distinct Clinicopathologic and Molecular Subtype Associated with Improved Disease-Specific Survival. Modern Pathology. https://doi.org/10.1016/j.modpat.2026.101094

Source records